Last reviewed · How we verify
ALT005 Ophthalmic Prep Solution — Competitive Intelligence Brief
phase 3
Ophthalmology
Small molecule
Live · refreshed every 30 min
Target snapshot
ALT005 Ophthalmic Prep Solution (ALT005 Ophthalmic Prep Solution) — Altacor Ltd.. ALT005 is an ophthalmic preparation designed to treat ocular surface disease through topical application to the eye.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| ALT005 Ophthalmic Prep Solution TARGET | ALT005 Ophthalmic Prep Solution | Altacor Ltd. | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- ALT005 Ophthalmic Prep Solution CI watch — RSS
- ALT005 Ophthalmic Prep Solution CI watch — Atom
- ALT005 Ophthalmic Prep Solution CI watch — JSON
- ALT005 Ophthalmic Prep Solution alone — RSS
Cite this brief
Drug Landscape (2026). ALT005 Ophthalmic Prep Solution — Competitive Intelligence Brief. https://druglandscape.com/ci/alt005-ophthalmic-prep-solution. Accessed 2026-05-15.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab